Skip to content
10-Q

Quarterly Report

ALPINE IMMUNE SCIENCES, INC.

0001626199-23-000126

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 9, 2023 58.1M sh
Shares Diluted Q3 2023 · Sep 30, 2023 49.22M sh
Shares Diluted Q3 2023 · Sep 30, 2023 48.29M sh
Shares Diluted Q3 2023 · Sep 30, 2022 31.57M sh
Shares Diluted Q3 2023 · Sep 30, 2022 31.56M sh
Capex Q3 2023 · Sep 30, 2023 $373K
Capex Q3 2023 · Sep 30, 2022 $296K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$60.04M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$26.97M
Short Term Debt Q3 2023 · Sep 30, 2023 $0
Short Term Debt Q3 2023 · Dec 31, 2022 $3.38M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $18.98M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $13.38M
Stockholders Equity Q3 2023 · Sep 30, 2023 $161.63M
Stockholders Equity Q3 2023 · Jun 30, 2023 $169.39M
Stockholders Equity Q3 2023 · Mar 31, 2023 $169.54M
Stockholders Equity Q3 2023 · Dec 31, 2022 $179.42M
Stockholders Equity Q3 2023 · Sep 30, 2022 $182.01M
Stockholders Equity Q3 2023 · Jun 30, 2022 $99.54M
Stockholders Equity Q3 2023 · Mar 31, 2022 $115.43M
Stockholders Equity Q3 2023 · Dec 31, 2021 $120.9M
Current Liabilities Q3 2023 · Sep 30, 2023 $51.82M
Current Liabilities Q3 2023 · Dec 31, 2022 $58M
Total Liabilities Q3 2023 · Sep 30, 2023 $78.92M
Total Liabilities Q3 2023 · Dec 31, 2022 $107.27M
Current Assets Q3 2023 · Sep 30, 2023 $197.42M
Current Assets Q3 2023 · Dec 31, 2022 $240.99M
Total Assets Q3 2023 · Sep 30, 2023 $240.55M
Total Assets Q3 2023 · Dec 31, 2022 $286.69M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.24
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.79
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.42
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.23
Eps Basic Q3 2023 · Sep 30, 2023 −$0.24
Eps Basic Q3 2023 · Sep 30, 2023 −$0.79
Eps Basic Q3 2023 · Sep 30, 2022 −$0.42
Eps Basic Q3 2023 · Sep 30, 2022 −$1.23
Sga Expense Q3 2023 · Sep 30, 2023 $5.44M
Sga Expense Q3 2023 · Sep 30, 2023 $15.85M
Sga Expense Q3 2023 · Sep 30, 2022 $4.61M
Sga Expense Q3 2023 · Sep 30, 2022 $13.58M
Rd Expense Q3 2023 · Sep 30, 2023 $19.15M
Rd Expense Q3 2023 · Sep 30, 2023 $57.97M
Rd Expense Q3 2023 · Sep 30, 2022 $17.59M
Rd Expense Q3 2023 · Sep 30, 2022 $51.49M
Net Income Q3 2023 · Sep 30, 2023 −$11.72M
Net Income Q3 2023 · Sep 30, 2023 −$38.14M
Net Income Q3 2023 · Jun 30, 2023 −$13.16M
Net Income Q3 2023 · Mar 31, 2023 −$13.27M
Net Income Q3 2023 · Sep 30, 2022 −$13.27M
Net Income Q3 2023 · Sep 30, 2022 −$38.9M
Net Income Q3 2023 · Jun 30, 2022 −$18.1M
Net Income Q3 2023 · Mar 31, 2022 −$7.53M
Operating Income Q3 2023 · Sep 30, 2023 −$14.55M
Operating Income Q3 2023 · Sep 30, 2023 −$45.8M
Operating Income Q3 2023 · Sep 30, 2022 −$13.83M
Operating Income Q3 2023 · Sep 30, 2022 −$37.78M
Revenue Q3 2023 · Sep 30, 2023 $10.04M
Revenue Q3 2023 · Sep 30, 2023 $28.02M
Revenue Q3 2023 · Sep 30, 2022 $8.37M
Revenue Q3 2023 · Sep 30, 2022 $27.29M